Diabetes Care in A Safety Net Hospital: Impact of a Pharmacist Transitional Care Service
- PMID: 38789106
- DOI: 10.1177/08971900241256776
Diabetes Care in A Safety Net Hospital: Impact of a Pharmacist Transitional Care Service
Abstract
Background: Diabetes is associated with increased risk of hospital readmission and imposes a significant economic burden on patients and healthcare systems. Literature suggests that pharmacist-led transitions-of-care (TOC) services reduce hospital readmissions and improve patient outcomes and data within safety-net hospitals is limited.
Methods: This was a single-center evaluation to assess the impact of pharmacist-led diabetes TOC services on hospital readmissions among diabetes patients vs standard care (SC). The evaluation included patients admitted from 11/1/2021-2/28/2022 and 10/19/2022-2/28/2023 who had a primary diagnosis of diabetes mellitus, were admitted for a diabetes-related reason, or were seen by the endocrine consult service during admission. The primary outcome was 30-day readmissions. Secondary outcomes included time to readmission, readmission diagnosis, changes in HbA1c, completion of follow-up visits, and number of pharmacist interventions at follow-up.
Results: There were 109 patients included (TOC n = 65; SC n = 44) and 13.8% (9/65) of TOC and 18.2% (8/44) of SC patients readmitted within 30 days (P = .235). Average time to readmission was 15.3 days in the TOC and 10.4 days in the SC cohorts. There were no diabetes-related readmissions in the TOC cohort. Over 60% (5/8) of readmissions in the SC cohort were diabetes-related. The average change in HbA1c was -2.5% in the TOC cohort and -1.2% in the SC cohort, P = .046. Approximately 51% of TOC patients completed an outpatient follow-up visit and nearly 70% of those patients had an intervention made at that time.
Conclusion: Pharmacist-led diabetes TOC services within a safety-net hospital may reduce hospital readmissions and improve clinical outcomes.
Keywords: diabetes; hospital readmissions; pharmacists; transitional care.
Conflict of interest statement
Declaration of Conflicting InterestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Similar articles
-
Evaluating the effects of a multidisciplinary transition care management program on hospital readmissions.Am J Health Syst Pharm. 2020 Jun 4;77(12):931-937. doi: 10.1093/ajhp/zxaa091. Am J Health Syst Pharm. 2020. PMID: 32436574
-
The effect of a pharmacist-led multidisciplinary transitions-of-care pilot for patients at high risk of readmission.J Am Pharm Assoc (2003). 2018 Sep-Oct;58(5):554-560. doi: 10.1016/j.japh.2018.05.008. Epub 2018 Jul 17. J Am Pharm Assoc (2003). 2018. PMID: 30017370 Clinical Trial.
-
Real-world evidence on impact of a pharmacist-led transitional care program on 30- and 90-day readmissions after acute care episodes.Am J Health Syst Pharm. 2020 Mar 24;77(7):535-545. doi: 10.1093/ajhp/zxaa012. Am J Health Syst Pharm. 2020. PMID: 32086512 Free PMC article.
-
Evaluating Pharmacist-Led Heart Failure Transitions of Care Clinic: Impact of Analytic Approach on Readmission Rate Endpoints.Curr Probl Cardiol. 2023 Feb;48(2):101507. doi: 10.1016/j.cpcardiol.2022.101507. Epub 2022 Nov 17. Curr Probl Cardiol. 2023. PMID: 36402220 Review.
-
Impact of pharmacist and physician collaborations in primary care on reducing readmission to hospital: A systematic review and meta-analysis.Res Social Adm Pharm. 2022 Jun;18(6):2922-2943. doi: 10.1016/j.sapharm.2021.07.015. Epub 2021 Jul 16. Res Social Adm Pharm. 2022. PMID: 34303610 Review.
LinkOut - more resources
Full Text Sources